Skip to main content
Signal8
Smith Weber Lara profile photo

Weber Lara Smith

CIK: 0002105051

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

FRACTYL HEALTH, INC. logo
GUTS

FRACTYL HEALTH, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • FRACTYL HEALTH, INC. logo
    GUTS

    FRACTYL HEALTH, INC.

    Jun 8, 2026
    Purchase(P)
    Direct
    20K shares at avg. $0.69$14K
  • FRACTYL HEALTH, INC. logo
    GUTS

    FRACTYL HEALTH, INC.

    Jan 12, 2026
    Award(A)

    Stock Option

    Direct
    1M shares-

1-2 of 2

About Smith Weber Lara

Smith Weber Lara (SEC CIK 0002105051) files insider reports with the SEC as Chief Financial Officer of FRACTYL HEALTH, INC. (GUTS).

Signal8 holds 3 ownership filings by Smith Weber Lara (1 Form 3, 2 Form 4), filed between Jan 14, 2026 and Jun 9, 2026. Those filings report 2 transactions, from Jan 12, 2026 to Jun 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Smith Weber Lara's filings is in BURLINGTON, MA.

Recent filings by Smith Weber Lara

  • Jun 8, 2026: Open-market purchase of GUTS shares (Form 4, code P).
  • Jan 12, 2026: Grant or award of GUTS derivative securities (Form 4, code A).

Other insiders filing for FRACTYL HEALTH, INC. (GUTS)

How to read Form 4 transaction codes